Today

Agents

Chat

Arena

Discover

More

App

West Pharmaceutical Q2 Adjusted EPS USD 2.37 Vs. IBES Estimate USD 2.08 - WST News | Rallies

West Pharmaceutical Q2 Adjusted EPS USD 2.37 Vs. IBES Estimate USD 2.08

WST•2026-07-23

Second-quarter results and outlook

Jul 23 (Reuters) - West Pharmaceutical Q2 net sales USD 872.3 million vs. IBES estimate USD 838.6 million.

Q2 EPS USD 2.15
outlook FY net sales USD 3,345-3,380 million vs. IBES estimate USD 3,332 million
outlook FY adjusted EPS USD 8.85-9.05 vs. IBES estimate USD 8.61

Related News

US Foods to host second-quarter 2026 earnings call and webcast

USFD•2026-07-23

Matador Resources to buy Paloma Permian for $1.3 billion

MTDR•2026-07-23

Cathay General Bancorp <CATY.O>: Stephens raises target price to $63 from $56

2026-07-23

SEI Investments Company <SEIC.O>: Morgan Stanley raises target price to $125.00 from $115.00

SEIC•2026-07-23

ZTO Express to host earnings call on second-quarter results

ZTO•2026-07-23